Skip to content

Ryan Christopher Gimple, PHD

NPI 1538803804ActiveIndividual· Internal Medicine· Saint Louis, MO

Internal Medicine (PHD) in Saint Louis, Missouri, licensed in MO, with an NPI issued in April 2022. Part D covered 615 prescriptions written in 2024, 76% of them generic. Novo Nordisk Inc was the largest of 4 companies reporting payments in 2025, $70.22 in all, mostly food and beverage.

Overview

NPI1538803804
StatusActive
Entity typeIndividual
CredentialPHD
Sole proprietorNo
NPI issuedApr 23, 2022
Last updated in NPPESJun 8, 2025
Certified by providerJun 8, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (MO)

Part D prescriptions in 2024

Prescriptions (claims)615 · 895 30-day fills
Patients81
Total drug cost$78,826
Generic share76% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$70.22 · 4 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$24.531
Incyte Corporation$16.901
Hema Biologics, LLC$15.041
Genzyme Corporation$13.751

What the 2025 payments were for

  • Food and Beverage$70.22 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Saint Louis

All 1,092 internal medicine physicians in Saint Louis · All internal medicine physicians in Missouri